Skip to main content

Table 3 The effect of Bestatin on survival time of nude mice

From: Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells

Cells Control-group Bestatin-group
HRA 13.8 ± 0.8 15.8 ± 2.5
SKOV-3 29.0 ± 3.0 *36.1 ± 6.5 (days)
  1. Mean survival days of PBS alone or bestatin treated mice with innoculation of 1.0 × 107 HRA and SKOV-3 cells, respectively. Data are expressed as the mean ± SD. *; p < 0.05